Given our ability to rapidly reach hundreds of thousands of people interested in clinical trials participation, we saw a unique opportunity to be part of the solution — helping researchers hasten patient enrollment in vaccine and other COVID-19 clinical trials.
March 19, 2020
ClinicalConnection.com, a leading website for clinical trial information and notifications, is offering to list all clinical trials for the novel Coronavirus (COVID-19) free-of-charge on its searchable clinical trials website and notification engine. Members of ClinicalConnection.com who have indicated an interest in COVID-19 clinical trials will be alerted if they reside near a study site. Each year over three million people visit http://www.clinicalconnection.com to search for clinical trials in their community and more than 650,000 members currently receive clinical trials notifications across numerous diseases and medical conditions.
“Speed is essential in effectively dealing with the unprecedented COVID-19 pandemic. Given our ability to rapidly reach hundreds of thousands of people interested in clinical trials participation, we saw a unique opportunity to be part of the solution — helping researchers hasten patient enrollment in vaccine and other COVID-19 clinical trials,” said Greg Conlan, Director of Operations for ClinicalConnection.com. Therefore, effective immediately ClinicalConnection.com will waive the usual listing and outreach fees for pharmaceutical companies, clinical research sites and hospitals who post clinical trials for COVID-19 on ClinicalConnection.com. The company will automatically apply a free listing discount when any COVID-19 study is posted. For additional information, please email: firstname.lastname@example.org or call 1-800-887-0639.
Individuals who have not yet registered on ClinicalConnection.com to receive free Clinical Trial Alerts are urged to do so at https://www.clinicalconnection.com/study-participant/join. They will be able to specify their interest in Clinical Trial Alerts about COVID-19 as well as study alerts for other diseases and medical conditions. Current members can update their profiles at any time to request notifications about newly listed clinical trials for COVID-19.
Research to develop and test a vaccine to protect against COVID-19 is ramping up quickly. The first clinical trial of a vaccine in Seattle, WA, testing 45 young, healthy volunteers is underway. Other clinical trial approaches may be available in the future. Associated Press (AP) reports that some researchers are hoping to quickly develop vaccines that provide temporary protection while a longer-lasting option is developed. Dr. Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases (NIAID) says even if initial tests go well, it could take up to 18 months before a vaccine offering longer protection is available for widespread use.
Clinical study enrollment is one of the highest barriers to timely completion of clinical trials — which can ultimately impact time-to-market for new pharmaceuticals and medical devices. Headquartered in Boston, Massachusetts, Clinical Connection, Inc. provides a patient recruiting clinical trials platform designed to help the clinical trials industry meet enrollment goals for clinical research studies. Clients include pharmaceutical and biopharmaceutical companies, medical device manufacturers, contract research organizations (CROs) academic and independent clinical research centers, hospitals and physician practices engaged in clinical research. ClinicalConnection.com has listed over 40,000 clinical trials in the US and worldwide and has referred over one million participants to clinical research studies.
Clinical Connection, Inc
email@example.com+1 800-887-0639 Ext: 912
Share article on social media or email:
Published at Thu, 19 Mar 2020 00:00:00 +0000